Oliva, Meritxell https://orcid.org/0000-0002-5068-213X
Sarkar, Mrinal K. https://orcid.org/0000-0001-8505-4259
March, Michael E. https://orcid.org/0000-0001-9173-6862
Saeidian, Amir Hossein
Mentch, Frank D.
Hsieh, Chen-Lin
Tang, Fanying
Uppala, Ranjitha
Patrick, Matthew T. https://orcid.org/0000-0002-6174-9002
Li, Qinmengge
Bogle, Rachael https://orcid.org/0000-0003-3544-3023
Kahlenberg, J. Michelle https://orcid.org/0000-0002-4006-8945
Watson, Deborah https://orcid.org/0000-0003-4329-7003
Glessner, Joseph T. https://orcid.org/0000-0001-5131-2811
Youssefian, Leila
Vahidnezhad, Hassan
Tsoi, Lam C.
Hakonarson, Hakon https://orcid.org/0000-0003-2814-7461
Gudjonsson, Johann E. https://orcid.org/0000-0002-0080-0812
Smith, Kathleen M. https://orcid.org/0000-0001-7833-3102
Riley-Gillis, Bridget https://orcid.org/0000-0001-7338-1156
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (NIH-P30-AR075043, NIH-P30-AR075043, NIH-P30-AR075043)
National Eczema Association (AD NEA23-CERG202)
Article History
Received: 30 May 2024
Accepted: 18 March 2025
First Online: 1 April 2025
Competing interests
: B.R.G., M.O., K.M.S. are employees of AbbVie. F.T. and C.H. were employees of AbbVie at the time of the study. J.E.G. (University of Michigan) has received research support from AbbVie, Janssen, Almirall, Prometheus Biosciences/Merck, BMS/Celgene, Boehringer Ingelheim, Galderma, Eli Lilly, and advisor to Sanofi, Eli Lilly, Galderma, BMS, Boehringer Ingelheim. M.K.S., R.U., M.T.P., Q.L., R.B., J.M.K., L.C.T. are employees of University of Michigan and have no funding to disclose. M.E.M., A.H.S., F.D.M., D.W., J.T.G, L.Y., H.V., H.H. are employees of the Children’s Hospital of Philadelphia and have no funding to disclose. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.